Business · 06/10/2026Updated: 10/17/2026 · 1 min read
FDA Awards Priority Review Voucher to Sponsor of Rare Pediatric Disease Product FAYUVI
Summary
The US Food and Drug Administration (FDA) has issued a priority review voucher to the sponsor of FAYUVI, a rare pediatric disease product, in accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act)
Original source language: Federal Register — Health and Human ServicesOpen original release →